-
-
-
-
-
-
-
Avoro Capital Believes Proposed Acquisition of Acceleron Pharma (XLRN) by Merck (MRK) Undervalues Acceleron Pharma
-
-
-
-
-
-
-
Bristol Myers Squibb Reports Second Quarter Financial Results for 2021
-
-
-
-
-
-
-
Acceleron Announces First Quarter 2021 REBLOZYL® Net Sales
-
-
-
-
-
-
-
Acceleron Announces Fourth Quarter and Full Year 2020 REBLOZYL® Net Sales
-
-
-
-
-
-
-
Acceleron to Webcast Second Quarter 2020 Operating and Financial Results on August 6, 2020
-
-
-
-
-
-
-
Reblozyl (luspatercept) Receives Positive CHMP Opinion for the Treatment of Adults with Anemia in Beta Thalassemia and Myelodysplastic Syndromes
-
-
-
-
-
-
-
Pre-Open Stock Movers 1/28: (DLPH) (XLRN) (ALKS) Higher (EROS) (BWA) (DDD) Lower (more...)
-
968,291 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All